Abstract:The ability of computed tomography (CT) to distinguish malignant from nonmalignant splenic masses was evaluated in 21 dogs with 24 masses. CT scans of the abdomen were performed pre- and postintravenous contrast medium administration before splenectomy or euthanasia. Splenic masses were evaluated objectively based on Hounsfield units (HU) and volume. Subjective criteria included location within the spleen (head, body, or tail), margination, homogeneity, and attenuation compared to the remaining splenic parench… Show more
“…Among them, hemangiosarcoma showed characteristic hypoechoic pattern during the early vascular phase. This finding concurred with those for sulphur hexafluoride microbubbles‐enhanced ultrasonography 5,6 and contrast‐enhanced computed tomography 21 . This hypoechoic area may correspond to the hemorrhagic or necrotic areas commonly associated with hemangiosarcoma.…”
Background: Contrast-enhanced ultrasonography with perflubutane microbubbles improves the diagnostic accuracy to differentiate benign and malignant focal liver lesions in dogs.Hypothesis: Perflubutane microbubbles-enhanced ultrasonography is useful for differentiation of benign from malignant focal splenic lesions in dogs.Animals: Twenty-nine clinical dogs with single or multiple focal splenic lesions detected by conventional ultrasonography. Methods: Prospective clinical observational study. Perflubutane microbubbles-enhanced ultrasonography was performed in 29 dogs with focal splenic lesions. Qualitative assessment of the enhancement pattern was performed in the early vascular, late vascular, and parenchymal phases.Results: In the early vascular phase, a hypoechoic pattern was significantly associated with malignancy (P 5 .02) with sensitivity of 38% (95% confidence interval [CI], 25-38%) and specificity of 100% (95% CI, 84-100%). In the late vascular phase, a hypoechoic pattern was significantly associated with malignancy (P 5 .001) with sensitivity of 81% (95% CI, 66-90%) and specificity of 85% (95% CI, 65-95%). There was no significant difference between malignant and benign lesions during the parenchymal phase.Conclusions and Clinical Importance: Hypoechoic splenic nodules in the early and late vascular phases with perflubutane microbubbles-enhanced ultrasonography are strongly suggestive of malignancy in dogs.
“…Among them, hemangiosarcoma showed characteristic hypoechoic pattern during the early vascular phase. This finding concurred with those for sulphur hexafluoride microbubbles‐enhanced ultrasonography 5,6 and contrast‐enhanced computed tomography 21 . This hypoechoic area may correspond to the hemorrhagic or necrotic areas commonly associated with hemangiosarcoma.…”
Background: Contrast-enhanced ultrasonography with perflubutane microbubbles improves the diagnostic accuracy to differentiate benign and malignant focal liver lesions in dogs.Hypothesis: Perflubutane microbubbles-enhanced ultrasonography is useful for differentiation of benign from malignant focal splenic lesions in dogs.Animals: Twenty-nine clinical dogs with single or multiple focal splenic lesions detected by conventional ultrasonography. Methods: Prospective clinical observational study. Perflubutane microbubbles-enhanced ultrasonography was performed in 29 dogs with focal splenic lesions. Qualitative assessment of the enhancement pattern was performed in the early vascular, late vascular, and parenchymal phases.Results: In the early vascular phase, a hypoechoic pattern was significantly associated with malignancy (P 5 .02) with sensitivity of 38% (95% confidence interval [CI], 25-38%) and specificity of 100% (95% CI, 84-100%). In the late vascular phase, a hypoechoic pattern was significantly associated with malignancy (P 5 .001) with sensitivity of 81% (95% CI, 66-90%) and specificity of 85% (95% CI, 65-95%). There was no significant difference between malignant and benign lesions during the parenchymal phase.Conclusions and Clinical Importance: Hypoechoic splenic nodules in the early and late vascular phases with perflubutane microbubbles-enhanced ultrasonography are strongly suggestive of malignancy in dogs.
“…9 CT is also useful to determine the origin and extent of abdominal mass lesions, and compared to ultrasonography, CT can better document the relationship of a mass with surrounding anatomic structures (Figure 6-5). 18,19 Infiltrative muscular lesions such as infiltrative lipomas and soft tissue sarcomas are routinely imaged with CT for both surgical and radiotherapy planning. 12,20 A contrast-enhanced scan is essential during CT to improve visualization of tumor margins, especially for infiltrative tumors such as feline vaccine-associated sarcomas.…”
Section: Imaging Modalitiesmentioning
confidence: 99%
“…116 FLT scan of a dog with a nasal adenocarcinoma. 18 F-sodium fluoride ( 18 F-NaF) is a PET tracer that is now commercially available for bone scans. 99,116 Hypoxic radiotracers include several in the nitroimidazole class, including 18 F-misonidazole, the more hydrophilic 18 F-fluoroazomycin (FAZA), and the more lipophilic version 2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3pentafluoropropyl)acetamide ( 18 F-EF5).…”
Section: Advancesmentioning
confidence: 99%
“…PET radiotracers for noninvasive imaging of tumor hypoxia have been found in human cancer trials to have value in prognostication, predicting response, and better defining hypoxic tumor volumes for boost radiation therapy. 18 F-NaF localizes to areas of high bone turnover similar to 99m Tc-MDP that is used for bone scintigraphy. 60 Cu-labeled diacetyl-bis(N 4methylthiosemicarbazone ( 60 Cu-ATSM) is a non-nitroimidazole tracer that is also being evaluated as a hypoxic tracer.…”
Section: Advancesmentioning
confidence: 99%
“…16 A,18 F-sodium fluoride ( 18 F-NaF) PET bone scan 3D maximum intensity projection (MIP) image of a dog with a proximal humeral osteosarcoma (black arrow) 6-months poststereotactic radiation therapy. Note the excellent skeletal image with multifocal uptake at the costochondral junctions, the injection catheter, the opposite shoulder joint, and the urinary bladder due to excretion.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.